Background: The epidemiology of nasopharyngeal carcinoma (NPC) has long been a
source of fascination due to the malignancy's striking geographic distribution, the …

Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from …

METHODS We conducted a thorough electronic search by Cochrane, EMBASE and
PubMed to identify relevant studies. Studies published up to the end of October 2018 were …

Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …

Compelling evidence indicates that Epstein Barr virus (EBV) infection is a prerequisite for
multiple sclerosis (MS). The disease may arise from a complex interplay between latent EBV …

Polygenic risk scores (PRS) have the potential to identify individuals at risk of diseases,
optimizing treatment, and predicting survival outcomes. Here, we construct and validate a …

Background Epstein Barr Virus (EBV) infects 90%-95% of all adults globally and causes~
1% of all cancers. Differing proportions of Burkitt's lymphoma (BL), gastric carcinoma (GC) …

Epstein–Barr virus-associated diseases are important global health concerns. As a group I
carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial-and …

Epstein–Barr virus (EBV) is a ubiquitous oncovirus associated with specific epithelial and
lymphoid cancers. Among the epithelial cancers, nasopharyngeal carcinoma (NPC) …

Abstract Using Epstein-Barr virus (EBV)-based markers to screen populations at high risk for
nasopharyngeal carcinoma (NPC) is an attractive preventive approach. Here, we develop a …